Trial Profile
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Denosumab (Primary) ; Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 30 Nov 2016 Status changed from recruiting to completed.
- 16 Jan 2013 New trial record